No abstract available
MeSH terms
-
Brain Damage, Chronic / etiology
-
Brain Damage, Chronic / prevention & control*
-
Endovascular Procedures / adverse effects
-
Endovascular Procedures / economics
-
Endovascular Procedures / statistics & numerical data
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / adverse effects
-
Fibrinolytic Agents / therapeutic use
-
Humans
-
Infusions, Intra-Arterial
-
Intracranial Hemorrhages / chemically induced
-
Intracranial Hemorrhages / prevention & control
-
Medicare
-
Neuroimaging
-
Odds Ratio
-
Prognosis
-
Randomized Controlled Trials as Topic* / methods
-
Randomized Controlled Trials as Topic* / statistics & numerical data
-
Severity of Illness Index
-
Stroke / complications
-
Stroke / drug therapy
-
Stroke / surgery*
-
Thrombolytic Therapy
-
Time Factors
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / adverse effects
-
Tissue Plasminogen Activator / therapeutic use
-
Treatment Failure
-
United States
-
Unnecessary Procedures
-
Vascular Surgical Procedures* / adverse effects
-
Vascular Surgical Procedures* / economics
-
Vascular Surgical Procedures* / statistics & numerical data
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator